Neuberger Berman Group’s Trevi Therapeutics TRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$146K Buy
+10,204
New +$176K ﹤0.01% 2191

Other funds holding TRVI

Neuberger Berman Group's TRVI Position: Q3 2026 in Review

Neuberger Berman Group opened a new position in Trevi Therapeutics (TRVI) in Q3 2026: 10,204 shares worth $146K. The stake represents ﹤0.01% of the portfolio and ranks #2191 among its holdings.

222 funds tracked by Wall St. Rank hold TRVI as of Q3 2026.

  • Neuberger Berman Group held 10,204 shares of Trevi Therapeutics worth $146K as of Q3 2026.
  • Trevi Therapeutics was a new Neuberger Berman Group position in Q3 2026.
  • Trevi Therapeutics made up ﹤0.01% of Neuberger Berman Group's portfolio in Q3 2026, its #2191 holding.
  • 222 funds tracked by Wall St. Rank held Trevi Therapeutics as of Q3 2026.

Based on Neuberger Berman Group's 13F filing for Q3 2026, filed 13 Nov 2026.